BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1909772)

  • 1. [Pharmacokinetic basis of mannitol administration in the treatment of raised ICP].
    Tanaka M; Yoshiyama Y; Kobayashi T; Tomonaga F; Kondo R; Takagi H; Ohwada T
    No Shinkei Geka; 1991 Jul; 19(7):619-24. PubMed ID: 1909772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannitol pharmacokinetics and serum osmolality in dogs and humans.
    Cloyd JC; Snyder BD; Cleeremans B; Bundlie SR; Blomquist CH; Lakatua DJ
    J Pharmacol Exp Ther; 1986 Feb; 236(2):301-6. PubMed ID: 3080582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of mannitol in subjects with increased ICP.
    Kobayashi T; Ichikawa T; Kondo R; Yoshiyama Y; Tomonaga F; Ohwada T
    Acta Neurochir Suppl (Wien); 1994; 60():538-40. PubMed ID: 7976642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The mechanism of intracranial pressure-reducing effect of mannitol].
    Takagi H; Saitoh T; Kitahara T; Ohwada T; Yada K
    No To Shinkei; 1984 Nov; 36(11):1095-102. PubMed ID: 6441589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of mannitol on intracranial pressure in relation to serum osmolality in a cat model of cerebral edema.
    Silver P; Nimkoff L; Siddiqi Z; Estrada R; Sagy M
    Intensive Care Med; 1996 May; 22(5):434-8. PubMed ID: 8796395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of NIK-242 inj. (20% erythritol) on intracranial pressure in dogs with acute obstructive hydrocephalus].
    Mase M; Ueda Y; Nagai H
    No To Shinkei; 1990 Jan; 42(1):79-85. PubMed ID: 2110812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon.
    Node Y; Nakazawa S
    Adv Neurol; 1990; 52():359-63. PubMed ID: 2118716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PVI in analyzing pressure volume relationship--effect of a bolus mannitol administration].
    Wachi A; Sato K; Inao S; Maset AL; Marmarou A
    No To Shinkei; 1990 Jul; 42(7):661-7. PubMed ID: 2121196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mannitol on increased intracranial pressure.
    McGraw CP; Howard G
    Neurosurgery; 1983 Sep; 13(3):269-71. PubMed ID: 6413884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mannitol bolus administration on intracranial pressure, cerebral extracellular metabolites, and tissue oxygenation in severely head-injured patients.
    Sakowitz OW; Stover JF; Sarrafzadeh AS; Unterberg AW; Kiening KL
    J Trauma; 2007 Feb; 62(2):292-8. PubMed ID: 17297315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannitol dose requirements in brain-injured patients.
    Marshall LF; SMith RW; Rauscher LA; Shapiro HM
    J Neurosurg; 1978 Feb; 48(2):169-72. PubMed ID: 624964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on intracranial pressure of furosemide combined with varying doses and administration rates of mannitol.
    Roberts PA; Pollay M; Engles C; Pendleton B; Reynolds E; Stevens FA
    J Neurosurg; 1987 Mar; 66(3):440-6. PubMed ID: 3102698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study.
    Kerwin AJ; Schinco MA; Tepas JJ; Renfro WH; Vitarbo EA; Muehlberger M
    J Trauma; 2009 Aug; 67(2):277-82. PubMed ID: 19667879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Furosemide and mannitol in the treatment of acute experimental intracranial hypertension.
    Wilkinson HA; Rosenfeld SR
    Neurosurgery; 1983 Apr; 12(4):405-10. PubMed ID: 6406929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannitol, intracranial pressure, and vasogenic edema.
    Hartwell RC; Sutton LN
    Neurosurgery; 1993 Mar; 32(3):444-50; discussion 450. PubMed ID: 8455770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of serum osmolality monitoring in patients with severe intracranial lesion].
    Ding Y; Duan A; Lu X
    Zhonghua Wai Ke Za Zhi; 1996 Apr; 34(4):224-8. PubMed ID: 9387687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study.
    Ware ML; Nemani VM; Meeker M; Lee C; Morabito DJ; Manley GT
    Neurosurgery; 2005 Oct; 57(4):727-36; discussion 727-36. PubMed ID: 16239885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertonic saline (7.5%) versus mannitol: a comparison for treatment of acute head injuries.
    Freshman SP; Battistella FD; Matteucci M; Wisner DH
    J Trauma; 1993 Sep; 35(3):344-8. PubMed ID: 8371290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mannitol treatment for increased intracranial pressure].
    Hansen PH; Rosenørn J; Westergaard L
    Ugeskr Laeger; 1983 Apr; 145(15):1125-7. PubMed ID: 6410563
    [No Abstract]   [Full Text] [Related]  

  • 20. Intracranial pressure during nifedipine-induced hypotension.
    Griffin JP; Cottrell JE; Hartung J; Shwiry B
    Anesth Analg; 1983 Dec; 62(12):1078-80. PubMed ID: 6650891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.